Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
63
Number of overlapping holdings
60.0%
% of BMED's 115 holdings also in IBB
28.1%
% of IBB's 261 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.7% | 8.2% | 3.7% |
 |
ARGENX SE ADR | 3.3% | 2.7% | 2.7% |
|
WATERS CORP | 2.0% | 2.3% | 2.0% |
|
NATERA INC | 1.5% | 2.0% | 1.5% |
|
BEIGENE LTD. SPONSORED ADR | 1.4% | 1.6% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to IBB
|
BOSTON SCIENTIFIC CORP | 4.9% |
|
INTUITIVE SURGICAL INC | 4.9% |
 |
ROCHE HOLDING AG-BR | 3.4% |
|
ABBVIE INC | 3.1% |
|
LONZA GROUP AG-REG | 2.7% |
|
ABBOTT LABORATORIES | 2.7% |
 |
MEDTRONIC PLC | 2.3% |
|
UCB SA | 2.2% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
EDWARDS LIFESCIENCES CORP | 1.6% |
BMED Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -8.4% |
|
REGENERON PHARMACEUTICALS | -7.3% |
|
AMGEN INC | -7.1% |
|
GILEAD SCIENCES INC | -4.5% |
|
METTLER-TOLEDO INTERNATIONAL | -2.6% |
|
ALNYLAM PHARMACEUTICALS INC | -2.6% |
|
IQVIA HOLDINGS INC | -2.6% |
|
BIOMARIN PHARMACEUTICAL INC | -1.5% |
|
INTRA-CELLULAR THERAPIES INC | -1.4% |
|
BIOGEN IDEC INC | -1.4% |